<section number="58-37f-304"><effdate>7/1/2026</effdate><histories><history>Amended by Chapter <modchap sess="2026GS">64</modchap>, 2026 General Session</history><modyear>2026</modyear></histories><catchline>Database utilization.</catchline><subsection number="58-37f-304(1)">As used in this section:<subsection number="58-37f-304(1)(a)">"Dispenser" means a licensed pharmacist, as described in Section <xref depth="3" refnumber="58-17b-303">58-17b-303</xref>, the pharmacist's licensed intern, as described in Section <xref depth="3" refnumber="58-17b-304">58-17b-304</xref>, or licensed pharmacy technician, as described in Section <xref depth="3" refnumber="58-17b-305">58-17b-305</xref>, working under the supervision of a licensed pharmacist who is also licensed to dispense a controlled substance under Chapter 37, Controlled Substances.</subsection><subsection number="58-37f-304(1)(b)">"Outpatient" means a setting in which an individual visits a licensed healthcare facility or a healthcare provider's office for a diagnosis or treatment but is not admitted to a licensed healthcare facility for an overnight stay.</subsection><subsection number="58-37f-304(1)(c)">"Prescriber" means an individual authorized to prescribe a controlled substance under Chapter 37, Controlled Substances.</subsection><subsection number="58-37f-304(1)(d)">"Schedule II opioid" means those substances listed in Subsection <xref depth="4" refnumber="58-37-108(2)(b)(i)">58-37-108(2)(b)(i)</xref> or <xref depth="4" refnumber="58-37f-304(2)(b)(ii)">(2)(b)(ii)</xref>.</subsection><subsection number="58-37f-304(1)(e)">"Schedule III opioid" means those substances listed in Subsection <xref depth="4" refnumber="58-37-4(2)(c)"/><xref depth="4" refnumber="58-37-108(2)(c)">58-37-108(2)(c)</xref> that are opioids.</subsection></subsection><subsection number="58-37f-304(2)"><subsection number="58-37f-304(2)(a)">A prescriber shall check the database for information about a patient before the first time the prescriber gives a prescription to a patient for a Schedule II opioid or a Schedule III opioid.</subsection><subsection number="58-37f-304(2)(b)">If a prescriber is repeatedly prescribing a Schedule II opioid or Schedule III opioid to a patient, the prescriber shall periodically review information about the patient in:<subsection number="58-37f-304(2)(b)(i)">the database; or</subsection><subsection number="58-37f-304(2)(b)(ii)">other similar records of controlled substances the patient has filled.</subsection></subsection><subsection number="58-37f-304(2)(c)">A prescriber may assign the access and review required under Subsection <xref depth="4" refnumber="58-37f-304(2)(a)">(2)(a)</xref> to one or more employees in accordance with Subsections <xref depth="4" refnumber="58-37f-301(2)(i)">58-37f-301(2)(i)</xref> and <xref depth="4" refnumber="58-37f-304(j)">(j)</xref>.</subsection><subsection number="58-37f-304(2)(d)"><subsection number="58-37f-304(2)(d)(i)">A prescriber may comply with the requirements in Subsections <xref depth="4" refnumber="58-37f-304(2)(a)">(2)(a)</xref> and <xref depth="4" refnumber="58-37f-304(b)">(b)</xref> by checking an electronic health record system if the electronic health record system:<subsection number="58-37f-304(2)(d)(i)(A)">is connected to the database through a connection that the division approves; and</subsection><subsection number="58-37f-304(2)(d)(i)(B)">displays the information from the database in a prominent manner for the prescriber.</subsection></subsection><subsection number="58-37f-304(2)(d)(ii)">The division may not approve a connection to the database if the connection does not satisfy the requirements the division makes in accordance with Section <xref depth="3" refnumber="58-37f-301">58-37f-301</xref>.</subsection></subsection><subsection number="58-37f-304(2)(e)">A prescriber is not in violation of the requirements of Subsection <xref depth="4" refnumber="58-37f-304(2)(a)">(2)(a)</xref> or <xref depth="4" refnumber="58-37f-304(b)">(b)</xref> if the failure to comply with Subsection <xref depth="4" refnumber="58-37f-304(2)(a)">(2)(a)</xref> or <xref depth="4" refnumber="58-37f-304(b)">(b)</xref>:<subsection number="58-37f-304(2)(e)(i)">is necessary due to an emergency situation as the division defines by rule the division makes in collaboration with the board and in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act;</subsection><subsection number="58-37f-304(2)(e)(ii)">is caused by a suspension or disruption in the operation of the database; or</subsection><subsection number="58-37f-304(2)(e)(iii)">is caused by a failure in the operation or availability of the internet.</subsection></subsection><subsection number="58-37f-304(2)(f)">The division may not take action against the license of a prescriber for failure to comply with this Subsection <xref depth="4" refnumber="58-37f-304(2)">(2)</xref> unless the failure occurs after the earlier of:<subsection number="58-37f-304(2)(f)(i)">December 31, 2018; or</subsection><subsection number="58-37f-304(2)(f)(ii)">the date that the division has the capability to establish a connection that meets the requirements the division makes in accordance with Section <xref depth="3" refnumber="58-37f-301">58-37f-301</xref> between the database and an electronic health record system.</subsection></subsection></subsection><subsection number="58-37f-304(3)">The division shall, in collaboration with the licensing boards for prescribers and dispensers:<subsection number="58-37f-304(3)(a)">develop a system that gathers and reports to prescribers and dispensers the progress and results of the prescriber's and dispenser's individual access and review of the database, as provided in this section; and</subsection><subsection number="58-37f-304(3)(b)">reduce or waive the division's continuing education requirements regarding opioid prescriptions, described in Section <xref depth="3" refnumber="58-37-303">58-37-303</xref>, including the online tutorial and test relating to the database, for prescribers and dispensers whose individual utilization of the database, as the division determines, demonstrates substantial compliance with this section.</subsection></subsection><subsection number="58-37f-304(4)">If the dispenser's access and review of the database suggest that the individual seeking an opioid may be obtaining opioids in quantities or frequencies inconsistent with generally recognized standards as provided in this section and Section <xref depth="3" refnumber="58-37f-201">58-37f-201</xref>, the dispenser shall reasonably attempt to contact the prescriber to obtain the prescriber's informed, current, and professional decision regarding whether the prescribed opioid is medically justified, notwithstanding the results of the database search.</subsection><subsection number="58-37f-304(5)"><subsection number="58-37f-304(5)(a)">The division shall review the database to identify any prescriber who has a pattern of prescribing opioids not in accordance with the recommendations of:<subsection number="58-37f-304(5)(a)(i)">the CDC Guideline for Prescribing Opioids for Chronic Pain, published by the Centers for Disease Control and Prevention;</subsection><subsection number="58-37f-304(5)(a)(ii)">the Utah Clinical Guidelines on Prescribing Opioids for Treatment of Pain, published by the Department of Health and Human Services; or</subsection><subsection number="58-37f-304(5)(a)(iii)">other publications describing best practices related to prescribing opioids as the division identifies in rule the division makes in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, and in consultation with the Medical Licensing Board.</subsection></subsection><subsection number="58-37f-304(5)(b)">The division shall offer education to a prescriber identified under this Subsection <xref depth="4" refnumber="58-37f-304(5)">(5)</xref> regarding best practices in the prescribing of opioids.</subsection><subsection number="58-37f-304(5)(c)">A decision by a prescriber to accept or not accept the education the division offers under this Subsection <xref depth="4" refnumber="58-37f-304(5)">(5)</xref> is voluntary.</subsection><subsection number="58-37f-304(5)(d)">The division may not use an identification the division has made under this Subsection <xref depth="4" refnumber="58-37f-304(5)">(5)</xref> or the decision by a prescriber to accept or not accept education the division offers under this Subsection <xref depth="4" refnumber="58-37f-304(5)">(5)</xref> in a licensing investigation or action by the division.</subsection><subsection number="58-37f-304(5)(e)">Any record the division creates as a result of this Subsection <xref depth="4" refnumber="58-37f-304(5)">(5)</xref> is a protected record under Section <xref depth="3" refnumber="63G-2-305">63G-2-305</xref>.</subsection></subsection><subsection number="58-37f-304(6)">The division may consult with a prescriber or health care system to assist the prescriber or health care system in following evidence-based guidelines regarding the prescribing of controlled substances, including the recommendations listed in Subsection <xref depth="4" refnumber="58-37f-304(5)(a)">(5)(a)</xref>.</subsection></section>